Blood Screening Market Segmentation:
Test Type Segment Analysis
Based on the test type, the automated screening segment in the blood screening market is projected to garner the highest share of 59.3% by the end of 2035. According to the January 2025 World Economic Forum report, the utilization of software tools by researchers assisted in reducing operational duration by 31%, which denotes a huge opportunity for the segment to effectively flourish in the market. In addition, autonomous robotic vehicles tend to deliver pharmaceuticals in hospitals and freeing up healthcare team members to focus on patients, thus suitable for enhancing the segment’s exposure.
Product Segment Analysis
Based on the product, the reagents and kits segment in the blood screening market is projected to account for the second-largest share of 50.1% by the end of the forecast period. The segment’s development is highly attributed to its crucial role in high recurring demand, along with gaining diagnostic accuracy. The segment effectively includes rapid test components, NAT assay kits, and ELISA reagents. Besides, key players are making intense investments in multiple assays, which have successfully enabled simultaneous numerous pathogens, as well as process reduction time. In addition, scalability and cost-effectiveness also make reagents in emerging economies, thereby suitable for the overall segment.
Technology Segment Analysis
Based on the technology, the nucleic acid testing (NAT) segment in the blood screening market is expected to hold the third-largest share of 42.7% during the forecast timeline. The segment’s growth is highly propelled by improving diagnosis processes and advancing health and medical services. According to the June 2024 Molecular Aspects of Medicine report, with the NAT implementation, the clinical sensitivity is more or less 95% to 97%, 97% to 99% for clinical specificity, and less than equal to 5% of clinical errors, thus augmenting the market across different nations.
Our in-depth analysis of the market includes the following segments:
|
Segment |
Subsegments |
|
Test Type |
|
|
Product |
|
|
Technology |
|
|
End user |
|
|
Disease Screening |
|
|
Sample Type |
|
